2. Industry Outlook
2.1. Impact of COVID-19 on Sepsis Diagnostics Market
2.2. Key Insights
2.3. Porter's Five Forces Model
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute Products
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Key Market Strategies
2.6.1. Contracts and Partnership
2.6.2. Business Expansion and Divestitures
2.6.3. Acquisitions & Mergers
2.6.4. New Product Launches
2.7. Market Drivers
2.7.1. Rise in Hospital-Acquired Infections Among Patients
2.7.2. Increased Prevalence of Sepsis
2.8. Market Restraints
2.8.1. High Cost Associated With the Instrument
2.8.2. Reimbursement Issues
2.9. Market Opportunities
2.9.1. Growth Opportunities in the Emerging Economies
3. Asia-Pacific Sepsis Diagnostics Market - by Technology
3.1. Microbiology
3.2. Immunoassay
3.3. Molecular Diagnostics
3.4. Other Technologies
4. Asia-Pacific Sepsis Diagnostics Market - by Diagnostic Method
4.1. Conventional Diagnostics
4.2. Automated Diagnostics
5. Asia-Pacific Sepsis Diagnostics Market - by Product
5.1. Blood Culture Media
5.2. Assay Kits & Reagents
5.3. Instruments
6. Asia-Pacific Sepsis Diagnostics Market - by Pathogen
6.1. Gram - Positive and Gram - Negative Bacterial Sepsis
6.2. Fungal Sepsis
6.3. Other Pathogens
7. Asia-Pacific Sepsis Diagnostics Market - by Testing Type
7.1. Laboratory Testing
7.2. Point-Of-Care Testing
8. Asia-Pacific Sepsis Diagnostics Market - Country Outlook
8.1. Country Analysis
8.1.1. China
8.1.2. Japan
8.1.3. India
8.1.4. Australia & New Zealand
8.1.5. South Korea
8.1.6. Asean Countries
8.1.7. Rest of Asia-Pacific
9. Competitive Landscape
9.1. Abbott Laboratories
9.2. Becton Dickinson and Company (Cr Bard)
9.3. Biomerieux Sa
9.4. Bruker Corporation
9.5. Cytosorbents
9.6. Danaher Corporation
9.7. EKF Diagnostics
9.8. F Hoffmann-La Roche
9.9. Immunexpress Inc
9.10. Luminex Corporation
9.11. Response Biomedical Corporation
9.12. T2 Biosystems Inc
9.13. Thermo Fisher Scientific Inc
10. Research Methodology & Scope
10.1. Research Scope & Deliverables
10.1.1. Objectives of Study
10.1.2. Scope of Study
10.2. Sources of Data
10.2.1. Primary Data Sources
10.2.2. Secondary Data Sources
10.3. Research Methodology
10.3.1. Evaluation of Proposed Market
10.3.2. Identification of Data Sources
10.3.3. Assessment of Market Determinants
10.3.4. Data Collection
10.3.5. Data Validation & Analysis
List of Tables
Table 1: Asia-Pacific Sepsis Diagnostics Market, Country Outlook, 2021-2028 (In $ Million)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: List of Contracts & Partnerships
Table 5: List of Business Expansions & Divestitures
Table 6: List of Acquisitions & Mergers
Table 7: List of New Product Launches
Table 8: Asia-Pacific Sepsis Diagnostics Market, by Technology, 2021-2028 (In $ Million)
Table 9: Asia-Pacific Sepsis Diagnostics Market, by Diagnostic Method, 2021-2028 (In $ Million)
Table 10: Asia-Pacific Sepsis Diagnostics Market, by Product, 2021-2028 (In $ Million)
Table 11: Asia-Pacific Sepsis Diagnostics Market, by Pathogen, 2021-2028 (In $ Million)
Table 12: Gram-Negative Bacteria Causing Sepsis
Table 13: Gram-Positive Bacteria Causing Sepsis
Table 14: Asia-Pacific Sepsis Diagnostics Market, by Testing Type, 2021-2028 (In $ Million)
Table 15: Asia-Pacific Sepsis Diagnostics Market, Country Outlook, 2021-2028 (In $ Million)
List of Figures
Figure 1: Asia-Pacific Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 2: Asia-Pacific Sepsis Diagnostics Market, by Technology, 2020 & 2028 (In %)
Figure 3: Asia-Pacific Sepsis Diagnostics Market, by Microbiology, 2021-2028 (In $ Million)
Figure 4: Asia-Pacific Sepsis Diagnostics Market, by Immunoassay, 2021-2028 (In $ Million)
Figure 5: Asia-Pacific Sepsis Diagnostics Market, by Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 6: Asia-Pacific Sepsis Diagnostics Market, by Other Technologies, 2021-2028 (In $ Million)
Figure 7: Asia-Pacific Sepsis Diagnostics Market, by Diagnostic Method, 2020 & 2028 (In %)
Figure 8: Asia-Pacific Sepsis Diagnostics Market, by Conventional Diagnostics, 2021-2028 (In $ Million)
Figure 9: Asia-Pacific Sepsis Diagnostics Market, by Automated Diagnostics, 2021-2028 (In $ Million)
Figure 10: Asia-Pacific Sepsis Diagnostics Market, by Product, 2020 & 2028 (In %)
Figure 11: Asia-Pacific Sepsis Diagnostics Market, by Blood Culture Media, 2021-2028 (In $ Million)
Figure 12: Asia-Pacific Sepsis Diagnostics Market, by Assay Kits & Reagents, 2021-2028 (In $ Million)
Figure 13: Asia-Pacific Sepsis Diagnostics Market, by Instruments, 2021-2028 (In $ Million)
Figure 14: Asia-Pacific Sepsis Diagnostics Market, by Pathogen, 2020 & 2028 (In %)
Figure 15: Asia-Pacific Sepsis Diagnostics Market, by Gram - Positive and Gram - Negative Bacterial Sepsis, 2021-2028 (In $ Million)
Figure 16: Asia-Pacific Sepsis Diagnostics Market, by Fungal Sepsis, 2021-2028 (In $ Million)
Figure 17: Asia-Pacific Sepsis Diagnostics Market, by Other Pathogens, 2021-2028 (In $ Million)
Figure 18: Asia-Pacific Sepsis Diagnostics Market, by Testing Type, 2020 & 2028 (In %)
Figure 19: Asia-Pacific Sepsis Diagnostics Market, by Laboratory Testing, 2021-2028 (In $ Million)
Figure 20: Asia-Pacific Sepsis Diagnostics Market, by Point-Of-Care Testing, 2021-2028 (In $ Million)
Figure 21: Asia-Pacific Sepsis Diagnostics Market, Country Outlook, 2020 & 2028 (In %)
Figure 22: China Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 23: Japan Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 24: India Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 25: Australia & New Zealand Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 26: South Korea Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 27: Asean Countries Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 28: Rest of Asia-Pacific Sepsis Diagnostics Market 2021-2028 (In $ Million)
